Lilly's case for Taltz helped by expanded approval - BioPharma Dive

Lilly's case for Taltz helped by expanded approval  BioPharma Dive

Eli Lilly on Monday won an expanded approval for its psoriasis and arthritis drug Taltz, securing a Food and Drug Administration OK that should help the ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases